🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Electrical Stimulation of the Mandibular Nerve for Pain and Function Management in Temporomandibular Disorders

RecruitingNAAges 18 Years - 65 YearsAllOrigenKinesis fisioterapia
NCT06265636 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Temporomandibular disorders (TMD) encompass dysfunction and pain of the masticatory muscles and temporomandibular joint (TMJ). Pain in the TMJ, restricted jaw movement, and joint sounds are common conditions in this disorder. This can impact patients' ability to perform daily activities such as eating, speaking, laughing, or yawning, significantly affecting their quality of life. The TMJ and masticatory muscles are innervated by the auriculotemporal branch and the mandibular nerve (V3), a branch of the trigeminal nerve. An estimated 60% to 70% of the population shows signs of TMD, of which up to 12% report intense symptoms requiring treatment. Percutaneous electrical nerve stimulation (PENS) could be a clinically relevant therapy in TMD patients applied through minimally invasive physiotherapy. To our knowledge, there are no trials evaluating the non-surgical clinical efficacy of PENS

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients with local myofascial pain and/or increased tension in the masticatory muscles. * Patients with myofascial pain from temporomandibular disorder (TMD) at the time, diagnosed according to the Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD). * Absence of temporomandibular disc displacement with or without reduction. * Pain in the masticatory muscles associated with limited mouth opening (\<40mm). * Good general health (absence of chronic diseases that may affect the temporomandibular joint or masticatory muscles). * Written consent to participate in the study. Exclusion Criteria: * Injury to the face or head during the research participation. * Undergone surgical procedures performed in the craniocervical region and degenerative neurological diseases. * Sudden illness of the patient that prevented participation in the study. * Will to end participation in the study. * Less than 2 weeks of evolution. * Inability to understand instructions or sign the informed consent. * Minor patients. * Regular medication, such as muscle relaxants, anticonvulsants, antidepressants, or anxiolytics * Facial paralysis. * Presenting a disease or infectious/inflammatory process of dental origin.
💊

What it tests

  • Percutaneous nerve stimulation
  • Manual therapy
  • exercise
📍

Where

1 site
Origenkinesis Fisioterapia
Alcorcón, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy